ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate

C33H32FN3O3S — CID 10231600

IUPACethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate
SMILESCCOC(=O)c1ccc2c(c1)nc(-c1ccc(OCc3sc(C)nc3-c3ccc(F)cc3)cc1)n2C1CCCCC1
InChIInChI=1S/C33H32FN3O3S/c1-3-39-33(38)24-13-18-29-28(19-24)36-32(37(29)26-7-5-4-6-8-26)23-11-16-27(17-12-23)40-20-30-31(35-21(2)41-30)22-9-14-25(34)15-10-22/h9-19,26H,3-8,20H2,1-2H3
InChIKeyJMAMRWKEUFFIOD-UHFFFAOYSA-N
MW569.70 g/mol
LogP8.54
Rot. Bonds8

About ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate

ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate (PubChem CID 10231600) has the molecular formula C33H32FN3O3S and a molecular weight of 569.70 g/mol. Its IUPAC name is ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate.

Molecular Properties

Compound Nameethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate
PubChem CID10231600
Molecular FormulaC33H32FN3O3S
Molecular Weight569.70 g/mol
Exact Mass569.21
IUPAC Nameethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate
SMILESCCOC(=O)c1ccc2c(c1)nc(-c1ccc(OCc3sc(C)nc3-c3ccc(F)cc3)cc1)n2C1CCCCC1
InChIInChI=1S/C33H32FN3O3S/c1-3-39-33(38)24-13-18-29-28(19-24)36-32(37(29)26-7-5-4-6-8-26)23-11-16-27(17-12-23)40-20-30-31(35-21(2)41-30)22-9-14-25(34)15-10-22/h9-19,26H,3-8,20H2,1-2H3
InChIKeyJMAMRWKEUFFIOD-UHFFFAOYSA-N
XLogP8.54
TPSA66.24 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500569.70
LogP ≤ 58.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Analyze ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate?
The IUPAC name of ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate (CID 10231600) is ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate.
What is the SMILES notation for ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate?
The canonical SMILES for ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate is CCOC(=O)c1ccc2c(c1)nc(-c1ccc(OCc3sc(C)nc3-c3ccc(F)cc3)cc1)n2C1CCCCC1.
What is the InChIKey of ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate?
The InChIKey is JMAMRWKEUFFIOD-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H32FN3O3S/c1-3-39-33(38)24-13-18-29-28(19-24)36-32(37(29)26-7-5-4-6-8-26)23-11-16-27(17-12-23)40-20-30-31(35-21(2)41-30)22-9-14-25(34)15-10-22/h9-19,26H,3-8,20H2,1-2H3.
What are the key properties of ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate?
ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate has a molecular weight of 569.70 g/mol, XLogP of 8.54, 8 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for ethyl 1-cyclohexyl-2-[4-[[4-(4-fluorophenyl)-2-methyl-1,3-thiazol-5-yl]methoxy]phenyl]benzimidazole-5-carboxylate is sourced from PubChem (CID 10231600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).